Precigen (PGEN)
(Delayed Data from NSDQ)
$3.12 USD
-0.07 (-2.19%)
Updated Oct 10, 2025 04:00 PM ET
After-Market: $3.10 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2025
Time: -- |
9/2025 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Precigen (PGEN) reported earnings of -$0.11 per share, beating the Zacks Consensus Estimate of $-0.14 per share. This reflects a positive earnings surprise of 21.43%. Look out for PGEN's next earnings release expected on November 13, 2025. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 11.11%.
Earnings History
Price & Consensus
Zacks News for PGEN
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
PGEN FAQs
Based on past history, Zacks believes Precigen, Inc. (PGEN) will report their next quarter earnings on November 13, 2025. For the next earning release, we expect the company to report earnings of -0.08 per share, reflecting a year-over-year increase of 11.11.
Based on past history, Zacks believes Precigen, Inc. (PGEN) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 13, 2025.
The Zacks Consensus Estimate for Precigen, Inc. (PGEN) for the quarter ending September 2025 is $-0.08 a share. We expect Precigen, Inc. (PGEN) to report earnings in line with the consensus estimate of $-0.08 per share
In the earnings report for the quarter ending in June 2024, Precigen, Inc. (PGEN) announced earnings of $-0.10 per share versus the Zacks Consensus Estimate of $-0.09 per share, representing a surprise of 11.11%.